Development of Diagnostics and Treatment of Urological Cancers
The purpose of the study is to evaluate whether state-of-the-art technologies such and next generation sequencing and drug sensitivity and resistance testing of patient derived tumour tissue can facilitate research translation and improve outcome of urologic cancers.
Principal investigator: Antti Rannikko
HUS Helsinki University Hospital, Abdominal Center, Urology
Contact information: Study nurse 050 427 1345
